Filter
1592
Filtered Results: 1592
Text search:
human
pharmaceutical
products
Featured
Recommendations
149
New Publications
451
Language
Document type
No document type
822
Studies & Reports
317
Guidelines
236
Manuals
81
Strategic & Response Plan
78
Fact sheets
21
Training Material
18
Situation Updates
10
Resource Platforms
4
Brochures
2
Infographics
2
Online Courses
1
Countries / Regions
Kenya
66
Global
57
Ethiopia
55
India
51
Sierra Leone
35
Nigeria
35
South Africa
35
Western and Central Europe
32
Uganda
30
Liberia
30
Rwanda
27
Ghana
26
Nepal
25
Namibia
25
Tanzania
23
Zambia
23
Ukraine
19
Philippines
19
Malawi
18
Africa
17
Bangladesh
16
Latin America and the Carribbean
14
Lesotho
13
Eastern Europe
13
Indonesia
13
Zimbabwe
12
Myanmar / Burma
12
Cambodia
11
South–East Asia Region
11
Eswatini/ Swaziland
10
Syria
9
Botswana
9
West and Central Africa
8
Eastern Europe and Central Asia
8
East and Southern Africa
7
Burkina Faso
6
Guinea
6
Asia
6
Congo, Democratic Republic of
6
Haiti
5
South Sudan
5
Cameroon
4
Albania
4
Senegal
4
Venezuela
4
Pakistan
4
North Macedonia
3
Thailand
3
China
3
Fiji
3
Laos
3
Mozambique
3
USA
3
Jordan
3
Middle East and North Africa
3
Western Pacific Region
3
North America
3
Russia
3
Sudan
3
Tajikistan
2
Serbia
2
Benin
2
Kyrgyzstan
2
Afghanistan
2
Peru
2
Germany
2
Jamaica
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Brazil
2
Moldova
2
Egypt
2
Georgia
2
Central African Republic
2
Mali
2
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Bulgaria
1
Armenia
1
Ireland
1
Saudi Arabia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
United Kingdom
1
Southern Africa
1
Sri Lanka
1
Yemen
1
Angola
1
Libya
1
Bhutan
1
Iraq
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
631
Clinical Guidelines
113
Public Health
85
Key Resources
82
Women & Child Health
42
Pharmacy & Technologies
23
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
AMR
176
Pharmacy
145
COVID-19
103
TB
76
HIV
70
Mental Health
69
NTDs
55
Rapid Response
54
Planetary Health
52
Global Health Education
38
Caregiver
29
Health Financing Toolbox
28
NCDs
28
Conflict
27
Ebola & Marburg
26
Specific Hazards
13
Refugee
10
Disability
10
Natural Hazards
8
Polio
8
Social Ethics
3
Zika
3
Cholera
1
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
This guide can inform any partner that manages or supports public health supply chains. Ministries of health, technical assistance partners, or non-governmental organization (NGO) operating distribution systems can all benefit from conducting a costing exercise and can use the material presented in ...
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
The power relations around global decisions which shape population health can be changed through new alliances and information flows. The Democratising Global Health Governance Initiative, of which WHO Watch is a project, is designed to contribute to improved population health (and health equity) th...
Lessons from the STEP-TB Project.
Accessed November 2017.
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
Med J DY Patil Univ 2017;10:229-33
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
